Strategies to enhance nasopharyngeal carcinoma screening in patients with adult-onset idiopathic inflammatory myopathies
- PMID: 38873854
- DOI: 10.1111/1756-185X.15215
Strategies to enhance nasopharyngeal carcinoma screening in patients with adult-onset idiopathic inflammatory myopathies
References
REFERENCES
-
- Qiang JK, Kim WB, Baibergenova A, Alhusayen R. Risk of malignancy in dermatomyositis and polymyositis: a systematic review and meta‐analysis. J Cutan Med Surg. 2017;21:131‐136.
-
- Oldroyd AGS, Callen JP, Chinoy H, et al. International guideline for idiopathic inflammatory myopathy‐associated cancer screening: an international myositis assessment and clinical studies group (IMACS) initiative. Nat Rev Rheumatol. 2023;19:805‐817.
-
- Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73:17‐48.
-
- Okekpa SI, S M N Mydin RB, Mangantig E, et al. Nasopharyngeal carcinoma (NPC) risk factors: a systematic review and meta‐analysis of the association with lifestyle, diets, socioeconomic and sociodemographic in Asian region. Asian Pac J Cancer Prev. 2019;20:3505‐3514.
-
- Ka‐Yue Chow L, Lai‐Shun Chung D, Tao L, et al. Epigenomic landscape study reveals molecular subtypes and EBV‐associated regulatory epigenome reprogramming in nasopharyngeal carcinoma. EBioMedicine. 2022;86:104357.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
